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Generalized canine demodicosis is a disease caused by Demodex 
spp. commonly associated with infection by Staphylococcus spp., 
normal inhabitants of dogs skin. Both microorganisms proliferate 
within the hair follicles causing folliculitis and furunculosis. In the past, 
systemic antibiotic therapy was supported for all dogs with secondary 
bacterial infection. Nowadays, as the incidence of skin infections with 
multi-resistant bacteria is increasing, a judicious use of systemic 
antibiotics is recommended. Thus, the Clinical Practice Guidelines on 
Demodicosis Treatment (2020) recommeds topical antibiotic therapy 




cytologic resolution of the skin infection. The main objective of this 
study was to evaluate the clinical and bacteriological cure of dogs with 
generalized demodicosis treated exclusively with miticidal, without 
antibiotic or antiseptic therapy. For this purpose, 4 patients with 
pustular demodicosis diagnosed by skin scraping and cytology were 
admitted for their attention at the Teaching Hospital of Small Animals 
(HEPA). On day 0, the animals were evaluated by a clinical score and 
skin bacteria samples were obtained by swabs from lesions. Then, 
patients initiated a non-antibiotic treatment as follows: 2 dogs were 
treated with afoxolaner 2.7-6.9 mg/kg on day 0 and day 28, and 2 dogs 
were treated with oral ivermectin at a dose of 0.5 mg/kg/24 h for 63 
days. On days 14, 35 and 56 post-treatment, clinical scores were 
recorded and cytology samples and swabs from skin lesions were 
obtained. Sample swabs were stored in Stuart medium up to 
overnight growth on Tryptic Soy Agar medium supplemented with 
10 % sterile bovine blood. Bacterial strain phenotypic identification was 
performed by conventional biochemical techniques. Clinical score 
decreased considerably throughout the treatment as shown in TABLE 1. 
Staphylococcus spp. was isolated from skin samples in all dogs on 
days 0 and 14 post treatment. However, the cultures became negative 
in three of four dogs at day 35, and the same in all dogs at day 56 post-
treatment. In conclusion, these preliminary results propose that 
pyoderma associated with canine demodicosis could be clinically, 
cytologically and bacteriologically resolved by a single miticidal 
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